.
Aim: To create a simple
risk-scale
calculator for patients with ACS.
Methods: In the retrospective
Timasheva, Yanina,
Kochetova, Olga,
Balkhiyarova, Zhanna,
Korytina, Gulnaz,
Prokopenko, Inga,
Nouwen, Arie (2025) , neurotransmitters, and β-cell function, to develop a
prognostic tool for MetS
risk. Methods: We genotyped 40 genetic
ZAGIDULLIN, N.SH.,
HAMITOVA, A.,
LAKMAN, I.,
KRIONI, I.,
GAREEVA, D.,
ZULKARNEEV, R.,
TULBAEV, E. (2020) in stratifying the
risk of unfavorable cardiovascular events in cardiac patients in post-MI period. Goal
VASILYEVA, E.V.,
SITDIKOVA, I.D.,
KAMALETDINOVA, A.A.,
LOPUSHOV, D.V.,
USMANOVA, I.N.,
GERASIMOVA, L.I. (2018) , the main
risks were identified and evaluated; their indices and hazard ratios were
calculatedGareev, Ilgiz,
Beylerli, Ozal,
Yang, Guang,
Izmailov, Adel,
Shi, Huaizhang,
Sun, Jinxian,
Zhao, Boxian,
Liu, Binbing,
Zhao, Shiguang (2021) and use of new diagnostic methods for IAs, they continue to pose a significant
risk of mortality